Trinity Biotech (TRIB) Competitors $0.79 +0.01 (+1.54%) Closing price 07/11/2025 03:58 PM EasternExtended Trading$0.76 -0.03 (-3.67%) As of 07/11/2025 05:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TRIB vs. IFRX, KRON, AVTX, ABVC, CUE, GANX, ATRA, RNXT, RENB, and ZIVOShould you be buying Trinity Biotech stock or one of its competitors? The main competitors of Trinity Biotech include InflaRx (IFRX), Kronos Bio (KRON), Avalo Therapeutics (AVTX), ABVC BioPharma (ABVC), Cue Biopharma (CUE), Gain Therapeutics (GANX), Atara Biotherapeutics (ATRA), RenovoRx (RNXT), Renovaro (RENB), and ZIVO Bioscience (ZIVO). These companies are all part of the "pharmaceutical products" industry. Trinity Biotech vs. Its Competitors InflaRx Kronos Bio Avalo Therapeutics ABVC BioPharma Cue Biopharma Gain Therapeutics Atara Biotherapeutics RenovoRx Renovaro ZIVO Bioscience Trinity Biotech (NASDAQ:TRIB) and InflaRx (NASDAQ:IFRX) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, valuation, analyst recommendations, dividends, earnings, media sentiment, risk and profitability. Which has more risk & volatility, TRIB or IFRX? Trinity Biotech has a beta of 0.8, indicating that its share price is 20% less volatile than the S&P 500. Comparatively, InflaRx has a beta of 1.29, indicating that its share price is 29% more volatile than the S&P 500. Does the media favor TRIB or IFRX? In the previous week, InflaRx had 6 more articles in the media than Trinity Biotech. MarketBeat recorded 7 mentions for InflaRx and 1 mentions for Trinity Biotech. Trinity Biotech's average media sentiment score of 0.93 beat InflaRx's score of 0.90 indicating that Trinity Biotech is being referred to more favorably in the media. Company Overall Sentiment Trinity Biotech Positive InflaRx Positive Do analysts rate TRIB or IFRX? InflaRx has a consensus target price of $6.60, suggesting a potential upside of 649.91%. Given InflaRx's stronger consensus rating and higher probable upside, analysts plainly believe InflaRx is more favorable than Trinity Biotech.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Trinity Biotech 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00InflaRx 0 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has better earnings & valuation, TRIB or IFRX? Trinity Biotech has higher revenue and earnings than InflaRx. InflaRx is trading at a lower price-to-earnings ratio than Trinity Biotech, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTrinity Biotech$61.56M0.23-$31.79M-$2.93-0.27InflaRx$180K328.23-$49.85M-$0.82-1.07 Do institutionals and insiders believe in TRIB or IFRX? 79.0% of Trinity Biotech shares are held by institutional investors. Comparatively, 42.4% of InflaRx shares are held by institutional investors. 8.2% of Trinity Biotech shares are held by company insiders. Comparatively, 16.3% of InflaRx shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is TRIB or IFRX more profitable? InflaRx has a net margin of 0.00% compared to Trinity Biotech's net margin of -51.64%. Trinity Biotech's return on equity of 0.00% beat InflaRx's return on equity.Company Net Margins Return on Equity Return on Assets Trinity Biotech-51.64% N/A -27.43% InflaRx N/A -64.17%-53.39% SummaryInflaRx beats Trinity Biotech on 9 of the 16 factors compared between the two stocks. Get Trinity Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for TRIB and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TRIB and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TRIB vs. The Competition Export to ExcelMetricTrinity BiotechMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.26M$10.56B$5.56B$9.11BDividend YieldN/A2.08%5.06%4.01%P/E Ratio-0.2716.8328.2320.27Price / Sales0.2330.16434.20100.92Price / CashN/A22.5637.1257.67Price / Book-0.413.668.045.49Net Income-$31.79M$235.43M$3.19B$250.45M7 Day Performance11.58%1.27%3.62%4.78%1 Month Performance23.05%5.34%5.98%9.58%1 Year Performance-75.99%-15.78%29.39%16.41% Trinity Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TRIBTrinity Biotech0.8367 of 5 stars$0.79+1.5%N/A-76.0%$14.26M$61.56M-0.27480IFRXInflaRx2.7928 of 5 stars$0.82+2.2%$6.60+704.9%-46.7%$53.87M$180K0.0060News CoverageHigh Trading VolumeKRONKronos Bio2.8059 of 5 stars$0.88+1.5%$1.63+84.7%-38.5%$53.72M$9.85M-0.82100AVTXAvalo Therapeutics2.96 of 5 stars$4.75-4.2%$30.00+531.6%-60.7%$53.71M$440K0.0040News CoverageABVCABVC BioPharma0.4089 of 5 stars$3.99+28.3%N/A+401.9%$52.81M$510K0.0030News CoverageGap UpHigh Trading VolumeCUECue Biopharma4.077 of 5 stars$0.70+0.7%$3.00+328.4%-18.5%$52.38M$9.29M0.0060Gap DownGANXGain Therapeutics2.1952 of 5 stars$1.60-5.3%$8.20+412.5%+25.4%$50.61M$50K0.0020News CoverageATRAAtara Biotherapeutics4.5544 of 5 stars$8.58+1.3%$17.75+106.9%-11.8%$50.46M$128.94M-2.31330Gap DownRNXTRenovoRx2.4173 of 5 stars$1.32-2.9%$7.25+449.2%-0.5%$49.74M$40K0.006RENBRenovaro1.9393 of 5 stars$0.30+2.6%N/A-81.4%$49.72MN/A0.0020News CoverageZIVOZIVO BioscienceN/A$13.00+8.4%N/A+59.8%$49.62M$15.85K-2.6610Gap Up Related Companies and Tools Related Companies InflaRx Competitors Kronos Bio Competitors Avalo Therapeutics Competitors ABVC BioPharma Competitors Cue Biopharma Competitors Gain Therapeutics Competitors Atara Biotherapeutics Competitors RenovoRx Competitors Renovaro Competitors ZIVO Bioscience Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TRIB) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Trinity Biotech PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Trinity Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TRIB Stock Alerts